120 related articles for article (PubMed ID: 9130310)
1. Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated.
Weiner I; Tarrasch R; Bernasconi E; Broersen LM; Rüttimann TC; Feldon J
Pharmacol Biochem Behav; 1997 Apr; 56(4):817-26. PubMed ID: 9130310
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
Ruob C; Elsner J; Weiner I; Feldon J
Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus.
Weiner I; Bernasconi E; Broersen LM; Feldon J
Behav Pharmacol; 1997 Oct; 8(5):442-57. PubMed ID: 9832983
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
Weiner I; Shadach E; Barkai R; Feldon J
Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
[TBL] [Abstract][Full Text] [Related]
5. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.
Ruob C; Weiner I; Feldon J
Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.
Trimble KM; Bell R; King DJ
Pharmacol Biochem Behav; 1997 Apr; 56(4):809-16. PubMed ID: 9130309
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine increases aversive conditioning to diffuse contextual stimuli and to a discrete trace stimulus when conditioned at higher footshock intensity.
Norman C; Cassaday HJ
J Psychopharmacol; 2003 Mar; 17(1):67-76. PubMed ID: 12680741
[TBL] [Abstract][Full Text] [Related]
9. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.
Killcross AS; Dickinson A; Robbins TW
Psychopharmacology (Berl); 1994 Jun; 115(1-2):185-95. PubMed ID: 7862894
[TBL] [Abstract][Full Text] [Related]
11. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
Weiner I; Schiller D; Gaisler-Salomon I
Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
[TBL] [Abstract][Full Text] [Related]
12. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
Weiner I; Lubow RE; Feldon J
Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
[TBL] [Abstract][Full Text] [Related]
13. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
Weiner I; Feldon J
Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
[TBL] [Abstract][Full Text] [Related]
14. Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans.
Salgado JV; Hetem LA; Vidal M; Graeff FG; Danion JM; Sandner G
Behav Brain Res; 2000 Dec; 117(1-2):61-7. PubMed ID: 11099758
[TBL] [Abstract][Full Text] [Related]
15. Disruption of latent inhibition to a contextual stimulus with systemic amphetamine.
Norman C; Cassaday HJ
Neurobiol Learn Mem; 2004 Jul; 82(1):61-4. PubMed ID: 15183172
[TBL] [Abstract][Full Text] [Related]
16. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
Feldon J; Weiner I
Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
Russig H; Murphy CA; Feldon J
Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice.
Chang T; Meyer U; Feldon J; Yee BK
Psychopharmacology (Berl); 2007 Apr; 191(2):211-21. PubMed ID: 17180617
[TBL] [Abstract][Full Text] [Related]
19. The D1 agonist SKF 38393 attenuates amphetamine-produced enhancement of responding for conditioned reward in rats.
Ranaldi R; Pantalony D; Beninger RJ
Pharmacol Biochem Behav; 1995 Sep; 52(1):131-7. PubMed ID: 7501655
[TBL] [Abstract][Full Text] [Related]
20. Effects of apomorphine and clozapine on conditioned freezing and latent inhibition.
Masson S; Avanzi V; Troncoso AC; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):935-43. PubMed ID: 14499310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
